Yanyan Long – Trademark Portfolio
Entity Type: 01
Yanyan Long holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 4 Nice Classification classes. Currently, 7 trademarks are registered. Notable registered marks include VIIBINI, DR.KACOME, DR.NEWSKY, LUCKEARTH, and SOUTHTREE. The owner is based in Hunan Province.
Matoupu Town, Li County,
Group 3, Shuangquansi Community,
Hunan Province 415500 , CN
Showing of trademarks Trademarks
Trademark Classifications
Yanyan Long's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Precious metals and their alloys; jewellery, precious stones; horological instruments
Frequently Asked Questions
How many trademarks does Yanyan Long have?
Yanyan Long has 7 U.S. trademarks filed with the USPTO. Of these, 7 registered.
What trademark classes does Yanyan Long file in?
Yanyan Long files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 14 (Jewelry), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Yanyan Long's most well-known trademarks?
Yanyan Long's registered trademark portfolio includes well-known marks such as VIIBINI, DR.KACOME, DR.NEWSKY, LUCKEARTH, and SOUTHTREE. These are among 7 currently registered trademarks in the portfolio.
What is Yanyan Long's trademark registration success rate?
Yanyan Long has a 100% trademark registration rate, with 7 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.